GSK Investigational Site
Phoenix, Arizona 85012
We've found
6 trials
at this facility
Systemic Lupus Erythematosus Clinical Trial
Updated: 12/31/1969
Safety and Effectiveness of Belimumab in Systemic Lupus Erythematosus Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Anaemia Clinical Trial
Updated: 12/31/1969
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
HIV INfections Clinical Trial
Updated: 12/31/1969
Switch Study to Evaluate Dolutegravir Plus Lamivudine in Virologically Suppressed Human Immunodeficiency Virus Type 1 Positive Adults (TANGO)
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cholestasis Clinical Trial
Updated: 12/31/1969
Dose Response Study of GSK2330672 for the Treatment of Pruritus in Patients With Primary Biliary Cholangitis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Herpes Zoster Clinical Trial
Updated: 12/31/1969
A Study to Assess Frailty of Subjects During ZOSTER-006 and ZOSTER-022
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
HIV INfections Clinical Trial
Updated: 12/31/1969
Phase 2b, Open-label, Multicenter, Rollover Study to Assess Antiviral Activity and Safety of Long-acting Cabotegravir (CAB LA) Plus Long-acting Rilpivirine (RPV LA), Administered Every 2 Months (Q2M), in Human Immunodeficiency Virus (HIV)- Positive Subjects From the LATTE Study
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials